CALGARY, AB, October 3, 2007 --- Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 15th annual BioPartnering Europe conference in London, U.K. on Tuesday, October 9 at 9 a.m. The conference will be held at the Queen Elizabeth II Conference Centre from October 7-9, 2007.
See the full release here.
BioPartnering Europe began as a partnership between the U.S. Commercial Service and Technology Vision Group LLC to bring about closer ties between American and European biotechnology companies. Each year BioPartnering Europe showcases a number of young companies from North America, Europe and other parts of the world based on the recommendation of leading bioinvestors. This year 30 companies will offer a 14-minute podium presentation in the main plenary hall. Each company will then be available for private meetings directly afterwards. In the past, BPE has featured many young companies that have gone on to become the industry's most important players.
See the list of presenters here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment